Consensus Abbott Laboratories

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 12:59:48 2024-12-04 pm EST			5-day change	1st Jan Change
115.98 ^USD	-0.27%		-2.42%	+5.45%

Nov. 25	Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis	CI
Nov. 20	Insulet Corporation Announces Omnipod® 5 System Now Compatible with Abbott's FreeStyle Libre 2 Plus Sensor in the U.S	CI

Evolution of the Average Target: Abbott Laboratories

average-target-price-chart ABBOTT-LABORATORIES

Evolution of the Target Price: Abbott Laboratories

target-price-consensus-chart ABBOTT-LABORATORIES

Changes in Analyst Recommendations: Abbott Laboratories

f9b8ea7ee6b.qleMm-Yy9DZtttsm9861JJPKa6Hf6xPpxKN-juJfnd8.-zzKyL9GkXhdzOgWvZvEE_77JdHsnkKs8NkY-YFt0OmaB_jrqECmBizdig~2155e5316ad86467a18332f0cc2c14c1

Analysts' recommendations: Abbott Laboratories

Barclays Adjusts Price Target on Abbott Laboratories to $149 From $143	Nov. 04	MT
Barclays Adjusts Abbott Laboratories Price Target to $149 From $143	Nov. 04	MT
Daiwa Securities Adjusts Price Target on Abbott Laboratories to $125 From $120	Oct. 23	MT
Argus Adjusts Price Target on Abbott Laboratories to $145 From $135	Oct. 21	MT
UBS Adjusts Price Target on Abbott Laboratories to $146 From $143, Maintains Buy Rating	Oct. 17	MT
Mizuho Adjusts Price Target on Abbott Laboratories to $130 From $115, Maintains Neutral Rating	Oct. 17	MT
Piper Sandler Adjusts Price Target on Abbott Laboratories to $133 From $131, Maintains Overweight Rating	Oct. 17	MT
Raymond James Adjusts Price Target on Abbott Laboratories to $132 From $129, Maintains Outperform Rating	Oct. 17	MT
Bernstein Adjusts Price Target on Abbott Laboratories to $138 From $133, Maintains Outperform Rating	Oct. 17	MT
Redburn Atlantic Adjusts Price Target on Abbott Laboratories to $120 From $113, Maintains Neutral Rating	Oct. 17	MT
Jefferies Adjusts Price Target on Abbott Laboratories to $125 From $120, Maintains Hold Rating	Oct. 17	MT
Morgan Stanley Adjusts Price Target on Abbott Laboratories to $117 From $107, Maintains Equalweight Rating	Oct. 17	MT
Citigroup Adjusts Price Target on Abbott Laboratories to $135 From $127, Maintains Buy Rating	Oct. 17	MT
Goldman Sachs Adjusts Price Target on Abbott Laboratories to $134 From $133, Maintains Buy Rating	Oct. 17	MT
Stifel Adjusts Price Target on Abbott Laboratories to $130 From $125, Maintains Buy Rating	Oct. 17	MT
BTIG Raises Abbott Laboratories Price Target to $139 From $135, Buy Rating Maintained	Oct. 16	MT
Evercore ISI Raises Abbott Laboratories Price Target to $128 From $124	Oct. 16	MT
JPMorgan Adjusts Price Target on Abbott Laboratories to $135 From $125, Maintains Overweight Rating	Oct. 10	MT
RBC Capital Adjusts Price Target on Abbott Laboratories to $130 From $125	Oct. 08	MT
Oppenheimer Initiates Abbott Laboratories at Outperform With $130 Price Target	Oct. 08	MT
Goldman Sachs Adjusts Price Target on Abbott Laboratories to $133 From $126	Oct. 07	MT
Evercore ISI Adjusts Abbott Laboratories Price Target to $124 From $120	Oct. 01	MT
Piper Sandler Initiates Abbott Laboratories at Overweight With $131 Price Target	Sep. 19	MT
Citigroup Adjusts Price Target on Abbott Laboratories to $127 From $119, Maintains Buy	Aug. 22	MT
Edward Jones Downgrades Abbott Laboratories to Hold From Buy	Jul. 30	MT

More recommendations

Sector Comparison:

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analyst Opinion	4m Revision of opinion	Divergence of analysts' opinions	Divergence of Target Price	Ecart obj. / dr
	ABBOTT LABORATORIES					+11.68%
	MEDTRONIC PLC					+12.51%
	BECTON, DICKINSON AND COMPANY					+27.04%
	CENCORA, INC.					+6.91%
	HOYA CORPORATION					+14.44%
	DEXCOM, INC.					+17.74%
	TERUMO CORPORATION					+7.02%
	WEST PHARMACEUTICAL SERVICES, INC.					+12.33%
	ZIMMER BIOMET HOLDINGS, INC.					+12.56%
	STERIS PLC					+15.11%
	Average					+13.73%
	Weighted average by Cap.					+13.56%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

116.29USD

Average target price

129.87USD

Spread / Average Target

+11.68%

High Price Target

149.00USD

Spread / Highest target

+28.13%

Low Price Target

104.00USD

Spread / Lowest Target

-10.57%

Analyst Consensus Detail

consensus-detail-chart ABBOTT-LABORATORIES

Consensus revision (last 18 months)

consensus-revision-chart ABBOTT-LABORATORIES

Analysts covering the company

Barclays
Daiwa Securities
Argus
UBS
Mizuho Securities
Piper Sandler
Raymond James
Bernstein
Redburn Atlantic
Jefferies & Co.
Morgan Stanley
Citigroup
Goldman Sachs
Stifel Nicolaus
BTIG
Evercore ISI
JPMorgan Chase
RBC Capital Markets
Oppenheimer
Wells Fargo Securities
Morningstar
Wolfe Research
BofA Securities
Atlantic Equities
SVB Leerink
Redburn
Cowen
Credit Suisse
J.P. Morgan Chase